Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
4507:TYO
Shionogi & Co Ltd
¥3,110.00
+0.52%
(+16.00) 1D
Apr 24, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4507...
Open
¥3,080
High
¥3,117
Low
¥3,074
Mkt. cap
2.77T
Avg. vol.
2.72M
Volume
2.28M
Dividend
2.12%
Quarterly dividend
¥16
Ex dividend date
Sep 29, 2025
P/E ratio
13.58
52-wk high
¥3,758
52-wk low
¥2,162
EPS
¥229
Shares outstanding
314.50M
No. of employees
5K
News stories
From sources across the web
Profile
Shionogi & Company, Limited is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana. Shionogi has business roots that date back to 1878, and was incorporated in 1919. Among the medicines produced are for hyperlipidaemia, antibiotics, and cancer medicines. In Japan it is particularly known as a producer of antimicrobial and antibiotics. Because of antibiotic resistance and slow growth of the antibiotic market, it has teamed up with US based Schering-Plough to become a sole marketing agent for its products in Japan. Shionogi had supported the initial formation of Ranbaxy Pharmaceuticals, a generic manufacturer based in India. In 2012 the company became a partial owner of ViiV Healthcare, a pharmaceutical company specialising in the development of therapies for HIV. The company is listed on the Tokyo Stock Exchange and Osaka Securities Exchange and is constituent of the Nikkei 225 stock index. In June 2023, Shionogi announced its acquisition of Qpex Biopharma for approximately $140m. Wikipedia
About Shionogi & Co Ltd
CEOIsao Teshirogi
Employees4.96K
Founded1878
HeadquartersOsaka, Osaka, Japan
SectorPharmaceutical industry
Websiteshionogi.com
Last report
Jan 30, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
-/ -JPY
Revenue / Estimate
147.72B/ (137.88B est.)JPY
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
104.67B
99.78B
113.18B
147.72B
Cost of goods sold
17.79B
12.32B
16.94B
25.09B
Cost of revenue
17.79B
12.32B
16.94B
25.09B
Research and development expenses
29.16B
24.89B
27.55B
29.87B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.87B
25.82B
27.56B
35.27B
Operating expense
56.78B
52.37B
56.57B
48.45B
Total operating expenses
74.57B
64.68B
73.51B
73.54B
Operating income
30.10B
35.10B
39.67B
74.18B
Other non operating income
-1.14B
-1.00M
-
-1.00M
EBT including unusual items
44.87B
46.33B
52.06B
92.89B
EBT excluding unusual items
53.35B
46.33B
52.06B
93.10B
Income tax expense
8.68B
6.98B
7.87B
18.21B
Effective tax rate
19.33%
15.07%
15.12%
19.60%
Other operating expenses
-2.00B
1.17B
979.00M
-17.25B
Net income
36.63B
39.36B
44.19B
74.68B
Net profit margin
35.00%
39.44%
39.04%
50.56%
Earnings per share
-
-
-
-
Interest and investment income
25.40B
13.56B
14.21B
20.53B
Interest expense
-
-2.33B
-1.82B
-1.61B
Net interest expenses
25.40B
11.23B
12.38B
18.92B
Depreciation and amortization charges
-3.26B
-
-485.00M
-
EBITDA
35.30B
40.11B
44.83B
80.21B
Gain or loss from assets sale
254.00M
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer